Program
Levetiracetam
Also written as “Levetiracetam (Keppra)”, “levetiracetam” and “Levetiracetam 250 mg”.
Its studies are mostly in Epilepsy · Epilepsies, Partial · Seizures · Cognitive Dysfunction · Epilepsy, Generalized, led by 8 companies.
Drug pageLevetiracetam: every studyMany companies study it; this page follows only the 72 they lead. All 204 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| UCB | 570 open or running | phase 4since Sep 8, 2005 | Mar 3, 2005 | none ahead |
| Hikma Pharmaceuticalsits history only | 40 open or running | no phasesince Jan 15, 2009 | Jan 15, 2009 | none ahead |
| Teva Pharmaceutical Industriesits history only | 40 open or running | phase 1since Feb 20, 2009 | Feb 20, 2009 | none ahead |
| AgeneBioits history only | 20 open or running | phase 3since Mar 28, 2018 | Mar 28, 2018 | none ahead |
| Dr. Reddy's Laboratoriesits history only | 20 open or running | phase 1since May 26, 2010 | May 26, 2010 | none ahead |
| Ache Laboratorios Farmaceuticosits history only | 10 open or running | phase 3since Jul 6, 2011 | Jul 6, 2011 | none ahead |
| Desitin Arzneimittelits history only | 10 open or running | phase 1since Dec 1, 2025 | Dec 1, 2025 | none ahead |
| Novartisits history only | 10 open or running | phase 1since Jul 24, 2009 | Jul 24, 2009 | none ahead |
Also a collaborator on its studies: PRA Health Sciences and Parexel.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of UCB only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 41 studies since Mar 3, 2005.
- Oct 22, 2010Phase 3 study in EpilepsyNCT01228747 · 361 enrolled · China, Japan
- Oct 26, 2010Phase 4 study in EpilepsyNCT01229735 · 343 enrolled · Korea, Republic of
- Feb 8, 2011Phase 3 study in EpilepsyNCT01292837 · 13 enrolled · Japan
- May 9, 2011Phase 3 study in Epilepsies, PartialNCT01375374 · 11 enrolled · Austria, Germany, Spain
- Jul 12, 2011Phase 1 study in Healthy VolunteersNCT01394224 · 25 enrolled · United Kingdom
- Jul 13, 2011Phase 3 study in EpilepsyNCT01398956 · 44 enrolled · Japan
- Jul 29, 2011Phase 2 study in EpilepsyNCT01407523 · 16 enrolled · Japan
- Dec 9, 20112 phase 4 studiesNCT01491113, NCT01498822
- Jan 5, 2012Phase 3 study in EpilepsyNCT01506882 · 71 enrolled · Japan
- Jun 11, 20122 phase 1 studies in Human VolunteersNCT01618903, NCT01618877
- Nov 7, 2012Phase 1 study in Healthy VolunteersNCT01725009 · 32 enrolled · Japan
- Sep 26, 2013Phase 3 study in EpilepsyNCT01954121 · 436 enrolled · China
- Nov 6, 2015Phase 1 study in Healthy VolunteersNCT02602860 · 13 enrolled · United States
- Nov 8, 2017Phase 3 study in SeizuresNCT03340064 · 38 enrolled · Japan
TargetBeta
“Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker”ChEMBL 37, by rule
Studies
All 57 UCB leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT03340064Seizures · Japan | 3 | Completed | Jun 1, 2021 | 38 |
| NCT02602860Healthy Volunteers · United States | 1 | Completed | Sep 2017 | 13 |
| NCT01954121Epilepsy · China | 3 | Completed | Sep 2015 | 436 |
| NCT01725009Healthy Volunteers · Japan | 1 | Completed | Dec 2012 | 32 |
| NCT01618903Human Volunteers · China | 1 | Completed | Jul 2012 | 24 |
| NCT01618877Human Volunteers · China | 1 | Completed | Jul 2012 | 24 |
| NCT01506882Epilepsy · Japan | 3 | Completed | Oct 2013 | 71 |
| NCT01498822Epilepsy · Korea, Republic of | 4 | Completed | Jul 2014 | 353 |
| NCT01491113Healthy Subjects · Japan | 4 | Completed | Nov 2012 | 30 |
| NCT01407523Epilepsy · Japan | 2 | Completed | Feb 2012 | 16 |
| NCT01398956Epilepsy · Japan | 3 | Completed | Apr 2016 | 44 |
| NCT01394224Healthy Volunteers · United Kingdom | 1 | Completed | Sep 2011 | 25 |
| NCT01375374Epilepsies, Partial · Austria, Germany, Spain | 3 | Terminated | Mar 2013 | 11 |
| NCT01292837Epilepsy · Japan | 3 | Completed | Jun 2013 | 13 |
| NCT01229735Epilepsy · Korea, Republic of | 4 | Completed | May 2015 | 343 |
| NCT01228747Epilepsy · China, Japan | 3 | Completed | Apr 2014 | 361 |
| NCT01063764Epilepsy · Japan | 3 | Completed | Apr 2011 | 73 |
| NCT00985348Healthy · United Kingdom | 1 | Completed | Oct 2009 | 26 |
| NCT00961441Epilepsy · United States | 2 | Completed | Mar 2010 | 25 |
| NCT00631150Epilepsy | 4 | Completed | Jul 2004 | 35 |
| NCT00630968Epilepsy | 4 | Completed | Feb 2004 | 1,541 |
| NCT00630630Epilepsy | 4 | Completed | Nov 2003 | 3 |
| NCT00630357Epilepsy | 4 | Completed | Jul 2004 | 14 |
| NCT00643500Epilepsies, Partial | 4 | Completed | May 2003 | 342 |
| NCT00615615Epilepsy | 3 | Completed | Mar 2003 | 216 |
| NCT00610454Epilepsy | 2 | Completed | Aug 2004 | 25 |
| NCT00612859Anxiety Disorders | 2 | Completed | Jun 2004 | 217 |
| NCT00600509Epilepsy | 2 | Completed | Jul 2003 | 216 |
| NCT00545012Seizures | 2 | Completed | May 2003 | 4 |
| NCT00544050Epilepsy | 2 | Completed | May 2003 | 13 |
| NCT00535392Epilepsy · United States, Belgium, France and more | 2 | Completed | Feb 2010 | 33 |
| NCT00505934Epilepsy · United States, Belgium, France and more | 2 | Completed | Mar 2010 | 19 |
| NCT00419393Epilepsy · United States, Mexico, Poland and more | 3 | Completed | Mar 2010 | 190 |
| NCT00419094Epilepsy · United States, Mexico, Poland and more | 3 | Completed | Sep 2009 | 228 |
| NCT00367432Epilepsy · Japan | 3 | Completed | Dec 2010 | 398 |
| NCT00368069Epilepsy · Brazil, Finland, India and more | 3 | Completed | May 2007 | 158 |
| NCT00291655Epilepsy · Belgium, Bulgaria, Finland and more | 3 | Completed | Apr 2008 | 130 |
| NCT00280696Epilepsies, Partial · Japan | 3 | Completed | Nov 2007 | 352 |
| NCT00245713Epilepsies, Partial | 4 | Completed | Nov 2004 | 40 |
| NCT00175955Dyskinesia, Drug-Induced · Belgium, Bulgaria | 2 | Completed | Dec 2005 | 70 |
| NCT00175903Epilepsy · Australia, Austria, Belgium and more | 3 | Completed | Oct 2007 | 1,701 |
| NCT00175890Epilepsies, Partial · United States, Argentina, Belgium and more | 3 | Completed | Jan 2007 | 116 |
| NCT00160654Epilepsies, Partial · Hong Kong, Malaysia, Philippines and more | 4 | Completed | Dec 12, 2006 | 251 |
| NCT00160628Epilepsies, Partial | 3 | Completed | Oct 2004 | 100 |
| NCT00160615Epilepsies, Partial | 3 | Completed | Jan 17, 2007 | 154 |
| NCT00160576Parkinson Disease | 2 | Completed | Nov 2004 | 30 |
| NCT00160550Epilepsy, Generalized | 3 | Completed | Jun 2005 | 154 |
| NCT00160511Neuralgia, Postherpetic | 2 | Completed | Aug 2005 | 170 |
| NCT00152516Epilepsies, Partial · United States, Belgium, Brazil and more | 3 | Completed | Jun 2008 | 255 |
| NCT00152373Epilepsies, Partial | 3 | Completed | May 2005 | 192 |
| NCT00150813Epilepsy, Tonic-Clonic · Czechia, Hungary, Poland and more | 3 | Completed | May 29, 2007 | 66 |
| NCT00150787Epilepsy, Tonic-Clonic | 3 | Completed | Nov 2005 | 250 |
| NCT00150774Epilepsy, Generalized | 3 | Completed | Dec 2004 | 116 |
| NCT00150748Epilepsy, Generalized | 3 | Completed | Jul 2007 | 217 |
| NCT00150735Epilepsy, Generalized | 3 | Completed | Jul 2005 | 580 |
| NCT00150709Epilepsies, Partial | 3 | Completed | Jan 25, 2006 | 223 |
| NCT00105040Epilepsies, Partial · United States, Canada, South Africa | 2 | Completed | Mar 2007 | 87 |
How it is read
Names in the registry
- “Levetiracetam”, 52 entries
- “Levetiracetam (Keppra)”, 4 entries
- “levetiracetam”, 3 entries
- “Levetiracetam 250 mg”, 3 entries
- “Levetiracetam 500 mg”, 3 entries
Conditions, from the studies’ own filings
- Epilepsy, 26 studies
- Epilepsies, Partial, 13 studies
- Seizures, 8 studies
- Cognitive Dysfunction, 2 studies
- Epilepsy, Generalized, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.